{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:18:56Z","timestamp":1788135536766,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Foundation of National Flagship Construction Department (Urology) of Collaboration between Traditional Chinese Medicine and Western Medicine","award":["[2024]No.221"],"award-info":[{"award-number":["[2024]No.221"]}]},{"name":"grants from Jiangsu Provincial Research Hospital","award":["YJXYY202204-YSA05, YJXYY202204-XKB08"],"award-info":[{"award-number":["YJXYY202204-YSA05, YJXYY202204-XKB08"]}]},{"name":"Young Elite Scientists Sponsorship Program by CACM","award":["CACM-2023-QNRC2-B21"],"award-info":[{"award-number":["CACM-2023-QNRC2-B21"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56466-w","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T08:33:37Z","timestamp":1781426017000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic efficacy of circulating tumor cell in clinically significant prostate cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Jiajun","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbo","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"issue":"9","key":"56466_CR1","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41585-022-00638-6","volume":"19","author":"H Van Poppel","year":"2022","unstructured":"Van Poppel, H. et al. Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future[J]. Nat. Rev. Urol. 19 (9), 562\u2013572 (2022).","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"56466_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41585-022-00648-4","volume":"20","author":"T Barrett","year":"2023","unstructured":"Barrett, T. et al. Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway[J]. Nat. Rev. Urol. 20 (1), 9\u201322 (2023).","journal-title":"Nat. Rev. Urol."},{"key":"56466_CR3","doi-asserted-by":"crossref","unstructured":"Sekhoacha, M. et al. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules 27 (17) (2022).","DOI":"10.3390\/molecules27175730"},{"issue":"5","key":"56466_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1158\/2159-8290.CD-15-1483","volume":"6","author":"C Alix-Panabi\u00e8res","year":"2016","unstructured":"Alix-Panabi\u00e8res, C. & Pantel, K. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy[J]. Cancer Discov. 6 (5), 479\u2013491 (2016).","journal-title":"Cancer Discov"},{"issue":"12","key":"56466_CR5","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1158\/1535-7163.MCT-22-0020","volume":"21","author":"U Swami","year":"2022","unstructured":"Swami, U. et al. External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer[J]. Mol. Cancer Ther. 21 (12), 1857\u20131861 (2022).","journal-title":"Mol. Cancer Ther."},{"issue":"19","key":"56466_CR6","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","volume":"14","author":"JS de Bono","year":"2008","unstructured":"de Bono, J. S. et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer[J]. Clin. Cancer Res. 14 (19), 6302\u20136309 (2008).","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"56466_CR7","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.eururo.2016.05.023","volume":"70","author":"D Lorente","year":"2016","unstructured":"Lorente, D. et al. Decline in Circulating Tumor Cell Count and Treatment Outcome in Advanced Prostate Cancer[J]. Eur. Urol. 70 (6), 985\u2013992 (2016).","journal-title":"Eur. Urol."},{"issue":"10","key":"56466_CR8","doi-asserted-by":"publisher","first-page":"e2437871","DOI":"10.1001\/jamanetworkopen.2024.37871","volume":"7","author":"A Goldkorn","year":"2024","unstructured":"Goldkorn, A. et al. Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer[J]. JAMA Netw. Open. 7 (10), e2437871 (2024).","journal-title":"JAMA Netw. Open."},{"issue":"6","key":"56466_CR9","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/JU.0000000000000704","volume":"203","author":"S Pak","year":"2020","unstructured":"Pak, S. et al. Association between Postoperative Detection of Circulating Tumor Cells and Recurrence in Patients with Prostate Cancer[J]. J. Urol. 203 (6), 1128\u20131134 (2020).","journal-title":"J. Urol."},{"key":"56466_CR10","doi-asserted-by":"crossref","unstructured":"Crook, T. et al. Accurate screening for early-stage breast cancer by detection and profiling of circulating tumor cells. Cancers (Basel) 14 (14) (2022).","DOI":"10.3390\/cancers14143341"},{"issue":"1","key":"56466_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1373\/clinchem.2018.287102","volume":"65","author":"K Pantel","year":"2019","unstructured":"Pantel, K., Hille, C. & Scher, H. I. Circulating Tumor Cells in Prostate Cancer: From Discovery to Clinical Utility[J]. Clin. Chem. 65 (1), 87\u201399 (2019).","journal-title":"Clin. Chem."},{"issue":"20","key":"56466_CR12","doi-asserted-by":"publisher","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","volume":"10","author":"WJ Allard","year":"2004","unstructured":"Allard, W. J. et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases[J]. Clin. Cancer Res. 10 (20), 6897\u20136904 (2004).","journal-title":"Clin. Cancer Res."},{"key":"56466_CR13","doi-asserted-by":"crossref","unstructured":"Poudineh, M. et al. Profiling circulating tumour cells and other biomarkers of invasive cancers[J]. Nat. Biomed. Eng., 2 (2):72\u201384. (2018).","DOI":"10.1038\/s41551-018-0190-5"},{"issue":"1","key":"56466_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/jnci\/djn419","volume":"101","author":"AM Sieuwerts","year":"2009","unstructured":"Sieuwerts, A. M. et al. Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells[J]. J. Natl. Cancer Inst. 101 (1), 61\u201366 (2009).","journal-title":"J. Natl. Cancer Inst."},{"key":"56466_CR15","doi-asserted-by":"publisher","first-page":"252361","DOI":"10.1155\/2011\/252361","volume":"2011","author":"SD Mikolajczyk","year":"2011","unstructured":"Mikolajczyk, S. D. et al. Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood[J]. J. Oncol. 2011, 252361 (2011).","journal-title":"J. Oncol."},{"issue":"1","key":"56466_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41698-022-00289-1","volume":"6","author":"S Chai","year":"2022","unstructured":"Chai, S. et al. Identification of epithelial and mesenchymal circulating tumor cells in clonal lineage of an aggressive prostate cancer case[J]. NPJ Precis Oncol. 6 (1), 41 (2022).","journal-title":"NPJ Precis Oncol."},{"issue":"1","key":"56466_CR17","doi-asserted-by":"publisher","first-page":"11810","DOI":"10.1063\/1.4780062","volume":"7","author":"I Cima","year":"2013","unstructured":"Cima, I. et al. Label-free isolation of circulating tumor cells in microfluidic devices: Current research and perspectives[J]. Biomicrofluidics 7 (1), 11810 (2013).","journal-title":"Biomicrofluidics"},{"issue":"1","key":"56466_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41698-017-0015-0","volume":"1","author":"C Renier","year":"2017","unstructured":"Renier, C. et al. Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology[J]. NPJ Precis Oncol. 1 (1), 15 (2017).","journal-title":"NPJ Precis Oncol."},{"issue":"5 Pt 1","key":"56466_CR19","doi-asserted-by":"publisher","first-page":"51910","DOI":"10.1103\/PhysRevE.83.051910","volume":"83","author":"Q Guo","year":"2011","unstructured":"Guo, Q., McFaul, S. M. & Ma, H. Deterministic microfluidic ratchet based on the deformation of individual cells[J]. Phys. Rev. E Stat. Nonlin Soft Matter Phys. 83 (5 Pt 1), 51910 (2011).","journal-title":"Phys. Rev. E Stat. Nonlin Soft Matter Phys."},{"issue":"3","key":"56466_CR20","doi-asserted-by":"publisher","first-page":"34114","DOI":"10.1063\/1.4812688","volume":"7","author":"BK Lin","year":"2013","unstructured":"Lin, B. K. et al. Highly selective biomechanical separation of cancer cells from leukocytes using microfluidic ratchets and hydrodynamic concentrator[J]. Biomicrofluidics 7 (3), 34114 (2013).","journal-title":"Biomicrofluidics"},{"issue":"11","key":"56466_CR21","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.15252\/emmm.201404033","volume":"6","author":"B Polzer","year":"2014","unstructured":"Polzer, B. et al. Molecular profiling of single circulating tumor cells with diagnostic intention[J]. EMBO Mol. Med. 6 (11), 1371\u20131386 (2014).","journal-title":"EMBO Mol. Med."},{"issue":"43","key":"56466_CR22","doi-asserted-by":"publisher","first-page":"18392","DOI":"10.1073\/pnas.1012539107","volume":"107","author":"SL Stott","year":"2010","unstructured":"Stott, S. L. et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip[J]. Proc. Natl. Acad. Sci. U S A. 107 (43), 18392\u201318397 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"19","key":"56466_CR23","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","volume":"26","author":"SJ Cohen","year":"2008","unstructured":"Cohen, S. J. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer[J]. J. Clin. Oncol. 26 (19), 3213\u20133221 (2008).","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"56466_CR24","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.21873\/invivo.13769","volume":"38","author":"P Pepe","year":"2024","unstructured":"Pepe, P. et al. PSMA PET\/CT Accuracy in Diagnosing Prostate Cancer Nodes Metastases[J]. Vivo 38 (6), 2880\u20132885 (2024).","journal-title":"Vivo"},{"issue":"5","key":"56466_CR25","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.urolonc.2015.12.003","volume":"34","author":"CP Meyer","year":"2016","unstructured":"Meyer, C. P. et al. Limited prognostic value of preoperative circulating tumor cells for early biochemical recurrence in patients with localized prostate cancer[J]. Urol. Oncol. 34 (5), 211\u2013235 (2016).","journal-title":"Urol. Oncol."},{"issue":"19","key":"56466_CR26","doi-asserted-by":"publisher","first-page":"7860","DOI":"10.1158\/0008-5472.CAN-09-0801","volume":"69","author":"KT Helzer","year":"2009","unstructured":"Helzer, K. T. et al. Circulating tumor cells are transcriptionally similar to the primary tumor in a murine prostate model[J]. Cancer Res. 69 (19), 7860\u20137866 (2009).","journal-title":"Cancer Res."},{"issue":"11","key":"56466_CR27","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1158\/2159-8290.CD-12-0222","volume":"2","author":"DT Miyamoto","year":"2012","unstructured":"Miyamoto, D. T. et al. Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer[J]. Cancer Discov. 2 (11), 995\u20131003 (2012).","journal-title":"Cancer Discov"},{"issue":"11","key":"56466_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1001\/jamaoncol.2016.1828","volume":"2","author":"HI Scher","year":"2016","unstructured":"Scher, H. I. et al. Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer[J]. JAMA Oncol. 2 (11), 1441\u20131449 (2016).","journal-title":"JAMA Oncol."},{"key":"56466_CR29","doi-asserted-by":"publisher","first-page":"k3519","DOI":"10.1136\/bmj.k3519","volume":"362","author":"D Ilic","year":"2018","unstructured":"Ilic, D. et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis[J]. BMJ 362, k3519 (2018).","journal-title":"BMJ"},{"issue":"9","key":"56466_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/jnci\/djq099","volume":"102","author":"HG Welch","year":"2010","unstructured":"Welch, H. G. & Black, W. C. Overdiagnosis in cancer[J]. J. Natl. Cancer Inst. 102 (9), 605\u2013613 (2010).","journal-title":"J. Natl. Cancer Inst."},{"issue":"6","key":"56466_CR31","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1097\/01.ju.0000181224.95276.82","volume":"174","author":"M Mullerad","year":"2005","unstructured":"Mullerad, M. et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer[J]. J. Urol. 174 (6), 2158\u20132163 (2005).","journal-title":"J. Urol."},{"key":"56466_CR32","doi-asserted-by":"crossref","unstructured":"Fiorentino, V. et al. Histopathological ratios to predict gleason score agreement between biopsy and radical prostatectomy. Diagnostics (Basel), 11 (1). (2020).","DOI":"10.3390\/diagnostics11010010"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56466-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56466-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56466-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:07:26Z","timestamp":1788134846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56466-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56466"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56466-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,14]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were in accordance with the Declaration of Helsinki and approved by the Ethics Committee of Affiliated Hospital of Nantong University. Informed consent of subjects was taken in this study.","order":2,"name":"Ethics","label":"Ethical Approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27175"}}